Evidence map›Paper›PMID 41629317›Full record

ArticleNature communications2026

Publisher Correction: Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis.

Alberto Langtry, Raul Rabadan, Lola Alonso, Ioan Filip, Sergio Sabroso-Lasa, Ane Moreno-Oya, Rita Lawlor, Alfredo Carrato, Rafael Alvarez-Gallego, Mar Iglesias and 26 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

36 authors.

Alberto LangtryGenetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
Raul RabadanDepartment of Systems Biology, Columbia University, New York, NY, USA.ORCID http://orcid.org/0000-0001-7946-9255
Lola AlonsoGenetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.ORCID http://orcid.org/0000-0002-3493-718X
Ioan FilipDepartment of Systems Biology, Columbia University, New York, NY, USA.
Sergio Sabroso-LasaGenetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.ORCID http://orcid.org/0000-0001-7002-556X
Ane Moreno-OyaGenetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.ORCID http://orcid.org/0009-0007-1296-763X
Rita LawlorARC-Net Center for Applied Research on Cancer, Department of Diagnostics and Public Health, Verona, Italy.
Alfredo CarratoCIBERONC, Madrid, Spain.
Rafael Alvarez-GallegoHM CIOCC Madrid (Centro Integral Oncológico Clara Campal). Hospital Universitario HM Sanchinarro. Instituto de Investigación Sanitaria HM Hospitales, Madrid, Spain.
Mar IglesiasCIBERONC, Madrid, Spain.
Xavier MoleroDepartment of Gastroenterology, Hospital Vall Hebron, Barcelona, Spain.
Matthias J LöhrGastrocentrum, Karolinska Institutet and University Hospital, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-7647-198X
Christoph W MichalskiDepartment of Surgery, Technical University of Munich, Munich, Germany.
José PereaDepartment of Surgery, Hospital 12 de Octubre, Madrid, Spain.ORCID http://orcid.org/0000-0001-5522-8844
Michael O'RorkeCentre for Public Health, Belfast, Queen's University Belfast, Belfast, UK.ORCID http://orcid.org/0000-0002-2425-3323
Victor M BarberàMolecular Genetics Laboratory, General University Hospital of Elche, Elche, Spain.
Adonina TardónDepartment of Medicine, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Oviedo, Spain.ORCID http://orcid.org/0000-0001-5150-1209
Antoni FarréDepartment of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Luís Muñoz-BellvísDepartment of Surgery, Hospital Universitario de Salamanca - IBSAL, Universidad de Salamanca, Salamanca; and CIBERONC, Madrid, Spain.ORCID http://orcid.org/0000-0002-7809-5201
Tatjana Crnogorac-JurcevicBarts Cancer Institute, Centre for Cancer Biomarkers and Biotherapeutics, Queen Mary University of London, London, UK.
Enrique Domínguez-MuñozDepartment of Gastroenterology, University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, Spain.
Thomas M GressDepartment of Gastroenterology, University Hospital of Giessen and Marburg, Marburg, Germany.ORCID http://orcid.org/0000-0002-9333-5461
William GreenhalfDepartment of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.
Linda SharpNational Cancer Registry Ireland and HRB Clinical Research Facility, University College Cork, Cork, Ireland.
Joaquim BalsellsDepartment of Surgery, Hospital Vall Hebron, Barcelona, Spain.
Eithne CostelloDepartment of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.ORCID http://orcid.org/0000-0002-0104-8992
Jörg KleeffDepartment of Surgery, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0003-3432-6669
Bo KongDepartment of Surgery, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-5281-9603
Josefina MoraDepartment of Clinical Biochemistry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Damian O'DriscollNational Cancer Registry Ireland and HRB Clinical Research Facility, University College Cork, Cork, Ireland.
Aldo ScarpaARC-Net Center for Applied Research on Cancer, Department of Diagnostics and Public Health, Verona, Italy.ORCID http://orcid.org/0000-0003-1678-739X
Weimin YeDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stokholm, Sweden.ORCID http://orcid.org/0000-0002-6859-4648
Francisco X RealCIBERONC, Madrid, Spain.ORCID http://orcid.org/0000-0001-9501-498X
Evangelina López de Maturana *Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain. melopezdm@cnio.es.ORCID http://orcid.org/0000-0001-9425-3911
Núria Malats *Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain. nmalats@cnio.es.
PanGenEU Consortium Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41629317
PMCPMC12864752

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.